ARCHIVES

Avastin-Zybrestat Combination Increases Progression-Free Survival in Phase II Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

Cost To Oncologist For Enrolling a Patient On Trial About $2,000, ASCO Survey Finds

June 11, 1999

Cetuximab Plus Irinotecan Increases PFS In Metastatic Colorectal Cancer, EPIC Finds

April 27, 2007

Senate Orders OMB T Increase NIH FTEs, Drop Rules On Apportionment

September 19, 1986

Sen. Mack Seeks Research Funding For Shark Cartilage

July 29, 1994

UCLA Hutchinson, UPa. Reportedly Winners Of Fast Neutron Awards

September 21, 1979

Opposition To Lederberg May Have Caused Delay In Panel Appointments; FY 19809 Funds Held Up

October 5, 1979